Clinical Trials Directory

Trials / Unknown

UnknownNCT03548740

Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection

Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection and Cervical Cytological Abnormalities.

Status
Unknown
Phase
Study type
Observational
Enrollment
151 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
25 Years – 50 Years
Healthy volunteers
Accepted

Summary

Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the risk of HPV infection, cervical cytological abnormalities.

Detailed description

Persistent infection with oncogenic Human Papillomavirus (HPV) is necessary but not sufficient for the development of cervical cancer. Additional factors correlated with HPV persistence include immunodeficiency caused by HIV, smoking, use of oral contraceptives and, more recently reported, vaginal dysbiosis. In a state of dysbiosis, there is a marked reduction of Lactobacillus and a high diversity of bacteria, with increased abundance of anaerobic bacterial species. Based on this, the investigators are going to analyze the changes of microbiota in women with high-risk HPV and the cervical lesions. And the investigators hope to figure out the difference and change in microbiota to realize the tanning of cervical lesions.

Conditions

Interventions

TypeNameDescription
BIOLOGICALHuman Papillomaviruswomen with high-risk Human Papillomavirus or not

Timeline

Start date
2018-09-01
Primary completion
2020-01-20
Completion
2020-05-20
First posted
2018-06-07
Last updated
2019-02-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03548740. Inclusion in this directory is not an endorsement.